The genetic spectrum of a Chinese series of patients with 46, XY disorders of the sex development.
46
XY disorder of sex development
genetic spectrum
pathogenic variants
whole-exome sequencing
Journal
Andrology
ISSN: 2047-2927
Titre abrégé: Andrology
Pays: England
ID NLM: 101585129
Informations de publication
Date de publication:
06 May 2023
06 May 2023
Historique:
revised:
10
04
2023
received:
19
12
2022
accepted:
28
04
2023
pubmed:
6
5
2023
medline:
6
5
2023
entrez:
6
5
2023
Statut:
aheadofprint
Résumé
The etiology of 46, XY disorders of sex development (46, XY DSD) is complex, and studies have shown that different series of patients with 46, XY DSD has different genetic spectrum. In this study, we aimed to investigate the underlying genetic etiology in a Chinese series of patients with 46, XY DSD by whole exome sequencing (WES). Seventy patients with 46, XY DSD were enrolled from the Peking Union Medical College Hospital (Beijing, China). The detailed clinical characteristics were evaluated, and peripheral blood was collected for WES to find the patients' rare variants (RVs) of genes related to 46, XY DSD. The clinical significance of the RVs was annotated according to American College of Medical Genetics and Genomics (ACMG) guidelines. A total of 57 RVs from nine genes were identified in 56 patients with 46, XY DSD, which include 21 novel RVs and 36 recurrent RVs. Based on the American ACMG guidelines, 43 variants were classified as pathogenic(P) or likely pathogenic (LP) variants and 14 variants were defined as variants of uncertain significance (VUS). P or LP variants were identified in 64.3% (45/70) patients of the series. Thirty-nine, 14, and 4 RVs were involved in the process of androgen synthesis and action, testicular determination and developmental process, and syndromic 46, XY DSD, respectively. The top three genes most frequently affected to cause 46, XY DSD were AR, SRD5A2, and NR5A1. Seven patients were found harboring RVs of the 46, XY DSD pathogenic genes identified in recent years, namely DHX37 in four patients, MYRF in two patients, and PPP2R3C in one patient. We identified 21 novel RVs of nine genes, which extended the genetic spectrum of 46, XY DSD pathogenic variants. Our study showed that 60% of the patients were caused by AR, SRD5A2 or NR5A1 P/LP variants. Therefore, polymerase chain reaction (PCR) amplification and Sanger sequencing of these three genes could be performed first to identify the pathogeny of the patients. For those patients whose pathogenic variants had not been found, whole-exome sequencing could be helpful in determining the etiology.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Natural Science Foundation of China
ID : 81971375
Organisme : Natural Science Foundation of Beijing
ID : 7212080
Organisme : Natural Science Foundation of Beijing
ID : 7202151
Informations de copyright
© 2023 American Society of Andrology and European Academy of Andrology.
Références
Cools M, Nordenström A, Robeva R, et al. Caring for individuals with a difference of sex development (DSD): a consensus statement. Nat Rev Endocrinol. 2018;14(7):415-429. doi:10.1038/s41574-018-0010-8
Délot EC, Vilain E. Towards improved genetic diagnosis of human differences of sex development. Nat Rev Genet. 2021;22(9):588-602. doi:10.1038/s41576-021-00365-5
Fan Y, Zhang X, Wang L, et al. Diagnostic application of targeted next-generation sequencing of 80 genes associated with disorders of sexual development. Sci Rep. 2017;7:44536. doi:10.1038/srep44536
Yu BQ, Liu ZX, Gao YJ, et al. Prevalence of gene mutations in a Chinese 46,XY disorders of sex development cohort detected by targeted next-generation sequencing. Asian J Androl. 2021;23(1):69-73. doi:10.4103/aja.aja_36_20
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med Off J Am Coll Med Genet. 2015;17(5):405-424. doi:10.1038/gim.2015.30
Rehder C, Bean LJH, Bick D, et al. Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med Off J Am Coll Med Genet. 2021;23(8):1399-1415. doi:10.1038/s41436-021-01139-4
Zhang W, Mao J, Wang X, et al. Case Report: novel compound heterozygotic variants in PPP2R3C gene causing syndromic 46, XY gonadal dysgenesis and literature review. Front Genet. 2022;13:871328. doi:10.3389/fgene.2022.871328
Baxter RM, Arboleda VA, Lee H, et al. Exome sequencing for the diagnosis of 46,XY disorders of sex development. J Clin Endocrinol Metab. 2015;100(2):E333-344. doi:10.1210/jc.2014-2605
Globa E, Zelinska N, Shcherbak Y, Bignon-Topalovic J, Bashamboo A, MсElreavey K. Disorders of sex development in a large Ukrainian cohort: clinical diversity and genetic findings. Front Endocrinol. 2022;13:810782. doi:10.3389/fendo.2022.810782
Xie QG, Luo P, Xia K, et al. 46, XY disorders of sex development: the use of NGS for prevalent variants. Hum Genet. doi:10.1007/s00439-022-02465-6
Eggers S, Sadedin S, van den Bergen JA, et al. Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort. Genome Biol. 2016;17(1):243. doi:10.1186/s13059-016-1105-y
White S, Ohnesorg T, Notini A, et al. Copy number variation in patients with disorders of sex development due to 46,XY gonadal dysgenesis. PloS One. 2011;6(3):e17793. doi:10.1371/journal.pone.0017793
Lourenço D, Brauner R, Rybczynska M, Nihoul-Fékété C, McElreavey K, Bashamboo A. Loss-of-function mutation in GATA4 causes anomalies of human testicular development. Proc Natl Acad Sci U S A. 2011;108(4):1597-1602. doi:10.1073/pnas.1010257108
Martinez de LaPiscina I, de Mingo C, Riedl S, et al. GATA4 variants in individuals with a 46,XY disorder of sex development (DSD) may or may not be associated with cardiac defects depending on second hits in other DSD genes. Front Endocrinol. 2018;9:142. doi:10.3389/fendo.2018.00142
Hamanaka K, Takata A, Uchiyama Y, et al. MYRF haploinsufficiency causes 46,XY and 46,XX disorders of sex development: bioinformatics consideration. Hum Mol Genet. 2019;28(14):2319-2329. doi:10.1093/hmg/ddz066
Känsäkoski J, Jääskeläinen J, Jääskeläinen T, et al. Complete androgen insensitivity syndrome caused by a deep intronic pseudoexon-activating mutation in the androgen receptor gene. Sci Rep. 2016;6:32819. doi:10.1038/srep32819